세계의 혈액 분석기 시장 규모는 2023년 40억 달러에서 2023년에서 2028년까지 예측기간 중 5.7%의 CAGR로 성장하여 2028년에는 53억 달러 규모로 성장할 것으로 예측됩니다.
시약·소모품 부문은 2023년 27억 달러에서 6.0%의 CAGR로 성장하여 2028년에는 36억 달러 규모로 성장할 것으로 예측됩니다. 또한 기기 부문은 2023년 10억 달러에서 4.8%의 CAGR로 성장하여 2028년에는 13억 달러 규모로 성장할 것으로 예측됩니다.
세계의 혈액 분석기 시장을 조사했으며, 시장 개요, 시장 영향요인과 시장 기회 분석, 특허 동향, 시장 규모 추정과 예측, 각종 부문·지역별 상세 분석, 임상시험 분석, 신기술 동향, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.
목차
제1장 서론
제2장 요약과 하이라이트
제3장 시장 및 기술 배경
- 혈액 분석기 역사
- 혈액 분석기 개요
- 유세포 분석
- 전기 임피던스
- 레이저 회절
- 주요 혈액 분석기
- 혈액 검사 파라미터
- 혈액 분석기 용도
- 빈혈
- 혈액암
- 감염
- 자가면역질환·유전성 혈액질환
- 기타
제4장 시장 역학
- 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
제5장 산업 개요
- 혈액 분석기 밸류체인
- R&D
- 제조
- 유통·판매
- 최종사용자 서비스·서포트
- 규제 상황
- 오리지널 시약과 서드파티 시약 비교
- 투자 수익률
제6장 COVID-19의 영향
제7장 임상시험 분석
- 임상시험 분석
- 임상시험 분석 : 연구 유형별
- 임상시험 분석 : 상황별
- 임상시험 분석 : 단계별
- 임상시험 분석 : 지역별
제8장 특허 리뷰
제9장 시장의 신기술
- 신기술
- 상품화
- 워크플로우
- 분석
- 임상 정보 관리
- 혈액학의 동향
- 디지털 형태학
- AI
- POC(Point of Care) 검사
제10장 시장 내역 : 제품/서비스별
- 시장 개요
- 시장 점유율과 예측
- 시약 및 소모품
- 기기
- 5부 및 6부 구성 혈액 분석기
- 3부 구성 혈액 분석기
- POC(Point of Care) 검사용 혈액 분석기
- 반자동 혈액 분석기
- 서비스
제11장 시장 내역 : 최종사용자별
- 시장 개요
- 시장 점유율과 예측
- 진단 센터
- 병원·진료소
- 연구기관
- 기타
제12장 시장 내역 : 지역별
제13장 경쟁 상황
- 시장 점유율 분석
- PESTEL 분석
- Porter's Five Forces 분석
- 주요 기업의 최근 동향
제14장 기업 개요
- ABBOTT
- BIO-RAD LABORATORIES, INC.
- BOULE DIAGNOSTICS AB
- DANAHER
- DIATRON
- EKF DIAGNOSTICS HOLDINGS PLC
- HORIBA LTD.
- NIHON KOHDEN CORP.
- NORMA INSTRUMENTS
- SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
- SIEMENS HEALTHINEERS AG
- SYSMEX CORP.
- TRANSASIA BIO-MEDICALS
- TRIVITRON HEALTHCARE
- WIENER LABORATORIOS SAIC
KSM
Highlights:
The global market for hematology analyzers is estimated to increase from $4.0 billion in 2023 to reach $5.3 billion by 2028, at a compound annual growth rate (CAGR) of 5.7% from 2023 through 2028.
The global market for hematology analyzers for reagents and consumables segment is estimated to increase from $2.7 billion in 2023 to reach $3.6 billion by 2028, at a CAGR of 6.0% from 2023 through 2028.
The global market for hematology analyzers for instruments is estimated to increase from $1.0 billion in 2023 to reach $1.3 billion by 2028, at a CAGR of 4.8% from 2023 through 2028.
Report Scope:
The current report provides detailed exposure to the hematology analyzer market. This report highlights the current and future market potential of hematology analyzers, along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections through 2028 and market rank for key players. It covers the competitive environment, regulatory scenario and outlines market share based on product/service and end user. Products/services include Instruments, Reagents and Consumables and Services. The market end users are hospitals and clinics, diagnostic centers, research institutes and other end users. This report includes company profiles of key players with detailed information on business segments, financials, product portfolios and recent developments. The report examines the impact of the COVID-19 pandemic on this market.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.
Report Includes:
- 19 data tables and 45 additional tables
- An overview of global market outlook for hematology analyzers
- Analyses of global market trends, with data from 2020-2023 and projections of compound annual growth rates (CAGRs) through 2028
- Identification of market trends, issues and forecast impacting the global hematology analyzers market and quantification of the market based on product/service, end user, and region
- Discussion on market drivers such as growing incidence of blood disorders, increased preference for automated hematology instruments, and technological advancements in hematology analyzers
- Discussion on recent advancements and innovations available in the market
- Comprehensive company profiles of key players in the market, including Abbott, Boule Diagnostics AB, EKF Diagnostics Holdings Plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corp., and Nihon Kohden Corp.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Summary and Highlights
- Highlights of the Market for Hematology Analyzers
Chapter 3 Market and Technology Background
- History of the Hematology Analyzer
- Introduction to the Hematology Analyzer
- Flow Cytometry
- Electrical Impedance
- Laser Diffraction
- Selection of Hematology Analyzers
- Blood Test Parameters
- Hematology Analyzer Applications
- Anemia
- Blood Cancer
- Infection
- Autoimmune and Genetic Blood Diseases
- Others
Chapter 4 Market Dynamics
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Chapter 5 Industry Overview
- Value Chain of Hematology Analyzers
- Research and Development
- Manufacturing
- Distribution and Sales
- Service and Support to End Users
- Regulatory Landscape
- Regulatory Landscape, North America
- Regulatory Landscape, Europe
- Regulatory Landscape, Asia-Pacific
- Regulatory Landscape, Rest of the World
- Original Reagents vs. Third-Party Hematology Reagents
- Return on Investment
Chapter 6 Impact of the COVID-19 Pandemic
- Impact of COVID-19 on the Hematology Analyzer Market
Chapter 7 Clinical Trial Analysis
- Clinical Trial Analysis
- Clinical Trial Analysis, by Type of Study
- Clinical Trial Analysis, by Status
- Clinical Trials Analysis, by Phase
- Clinical Trial Analysis, by Region
Chapter 8 Patent Review
- Patents, by Year
- By Top Applicant
- By Top Owner
- By Jurisdiction
Chapter 9 Emerging Technologies in the Market
- Emerging Technology, Hematology Analyzer Market
- Commercialization
- Workflow
- Analysis
- Clinical Information Management
- Trends in Hematology
- Digital Morphology
- Artificial Intelligence (AI)
- Point-of-Care-Testing
Chapter 10 Market Breakdown by Product/Service
- Market Overview
- Market Share and Forecast
- Reagents and Consumables
- Instruments
- 5- and 6-part Hematology Analyzers
- 3-part Hematology Analyzers
- Point-of-care Testing Hematology Analyzers
- Semi-automatic Hematology Analyzers
- Services
Chapter 11 Market Breakdown by End User
- Market Overview
- Market Share and Forecast
- Diagnostic Centers
- Hospitals and Clinics
- Research Institutions
- Other End Users
Chapter 12 Market Breakdown by Region
- Global Market for Hematology Analyzer by Region
- North America
- U.S.
- Canada
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Europe
- Germany
- UK
- Italy
- France
- Rest of Europe
- Rest of the World
Chapter 13 Competitive Landscape
- Market Share Analysis
- Sysmex Corporation
- Danaher
- PESTEL Analysis
- Politics
- Economy
- Society
- Technology
- Law
- Environment
- Porter's Five Forces Analysis
- Bargaining Power of Supplier: Medium
- Bargaining Power of Buyers: Medium
- The Threat of Substitutes: Low
- The Threat of New Entrants: Moderate
- The Intensity of Competitive Rivalry: High
- Recent Developments of Key Market Players
Chapter 14 Company Profiles
- ABBOTT
- BIO-RAD LABORATORIES, INC.
- BOULE DIAGNOSTICS AB
- DANAHER
- DIATRON
- EKF DIAGNOSTICS HOLDINGS PLC
- HORIBA LTD.
- NIHON KOHDEN CORP.
- NORMA INSTRUMENTS
- SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
- SIEMENS HEALTHINEERS AG
- SYSMEX CORP.
- TRANSASIA BIO-MEDICALS
- TRIVITRON HEALTHCARE
- WIENER LABORATORIOS SAIC
